Featured Research

from universities, journals, and other organizations

Diverticulosis Not Associated With Higher Incidence Of Polyps, Study Finds

Date:
October 26, 2009
Source:
Henry Ford Health System
Summary:
A new study questions the need for aggressive screening for colonic polyps in patients with diverticulosis. The study sought to determine if asymptomatic patients with diverticular disease are at higher or lower risk for developing colonic polyps, abnormal growths found in the wall of the colon that sometimes become cancerous.

A Henry Ford Hospital study questions the need for aggressive screening for colonic polyps in patients with diverticulosis.

The study sought to determine if asymptomatic patients with diverticular disease are at higher or lower risk for developing colonic polyps, abnormal growths found in the wall of the colon that sometimes become cancerous.

"We found that patients with diverticulosis have a lower incidence of polyps overall and a tendency for less-advanced polyps," says Ali Nawras, M.D., chief of Endoscopy Services, Division of Gastroenterology at Henry Ford Hospital, and lead author of the study. "These results suggest that for patients with diverticulosis, a less-aggressive surveillance regimen could be appropriate."

The study results will be presented Oct. 26 at the American College of Gastroenterology's Annual Scientific Meeting in San Diego.

Colonic polyps and diverticulosis are common conditions in Western countries and both diseases share common predisposing factors such as older age and low-fiber diet. However, there has been conflicting data on the association between the presence of diverticulosis and colonic polyps.

According to the National Digestive Diseases Information Clearing House, about 10 percent of Americans older than 40, and half of those over age 60, have diverticulosis, a condition where small pouches in the lining of the colon bulge outward through weak spots. When the pouches become inflamed, the condition can lead to bleeding, serious infections, small tears or blockages in the colon.

Henry Ford physicians looked at 1,668 patients, all who had undergone full colonoscopy and had an average risk for colon cancer. The case group (899 patients) included those with diverticulosis and the control group (769 patients) did not. The incidence of polyps was significantly lower in the case group, (223, 24%) compared to the control group (336, 43%).

A subanalysis for different polyp sizes and pathologies was also conducted. Polyps were considered high-risk if they were greater than 1 cm in size, or had tubulo-villous or cancer pathology. Subjects with diverticulosis had a significantly lower rate of high-risk polyps, (36, 4.1%), than those without diverticulosis, (76, 6.8%).


Story Source:

The above story is based on materials provided by Henry Ford Health System. Note: Materials may be edited for content and length.


Cite This Page:

Henry Ford Health System. "Diverticulosis Not Associated With Higher Incidence Of Polyps, Study Finds." ScienceDaily. ScienceDaily, 26 October 2009. <www.sciencedaily.com/releases/2009/10/091026125351.htm>.
Henry Ford Health System. (2009, October 26). Diverticulosis Not Associated With Higher Incidence Of Polyps, Study Finds. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/10/091026125351.htm
Henry Ford Health System. "Diverticulosis Not Associated With Higher Incidence Of Polyps, Study Finds." ScienceDaily. www.sciencedaily.com/releases/2009/10/091026125351.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins